Research shows that abdominal or visceral fat, the deep fat surrounding internal organs is strongly linked with cancer risk, ...

You may look slim, fit into smaller clothes, and even be told your weight is ‘normal’, but still be at risk of serious health problems. This is the hidden danger of what many doctors describe as ...

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...

Roughly three million Canadian adults are now taking GLP-1 drugs, such as Ozempic and Mounjaro, with another two million ...

Microplastics have been found accumulating everywhere from our water to our body tissues, but many of the claims have come ...

Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) in a phase 2a clinical study, meeting the trial’s primary end point and ...

You check your reports. HbA1c is within range. The doctor says blood sugar looks fine. Yet, by mid-morning, energy dips. After lunch, eyes feel heavy. By evening, even small tasks feel draining.So ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

Alhaji Oladotun Odunaye retired at the directorate level from the Independent National Electoral Commission (INEC) in 2016, after decades of service in Ogun and Edo states and electoral assignments in ...

Health treatments containing GLP-1 have been used succesfully to fight diabetes, obesity and a number of other conditions ...

Fatty liver, or hepatic steatosis, is becoming increasingly common in India, driven largely by lifestyle and dietary changes. Rising obesity rates, even among people who appear slim but carry excess ...